Logo image of SPCB

SUPERCOM LTD (SPCB) Stock Fundamental Analysis

NASDAQ:SPCB - Nasdaq - IL0010830961 - Common Stock - Currency: USD

7.94  +0.23 (+2.92%)

After market: 7.99 +0.05 (+0.63%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPCB. SPCB was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While SPCB seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SPCB has reported negative net income.
In the past 5 years SPCB always reported negative net income.
In the past 5 years SPCB always reported negative operating cash flow.
SPCB Yearly Net Income VS EBIT VS OCF VS FCFSPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

SPCB's Return On Assets of 3.09% is fine compared to the rest of the industry. SPCB outperforms 65.32% of its industry peers.
SPCB has a better Return On Equity (11.09%) than 79.03% of its industry peers.
Industry RankSector Rank
ROA 3.09%
ROE 11.09%
ROIC N/A
ROA(3y)-16.94%
ROA(5y)-19.82%
ROE(3y)-184.28%
ROE(5y)-170.19%
ROIC(3y)N/A
ROIC(5y)N/A
SPCB Yearly ROA, ROE, ROICSPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

With a decent Profit Margin value of 5.70%, SPCB is doing good in the industry, outperforming 75.00% of the companies in the same industry.
With an excellent Gross Margin value of 51.80%, SPCB belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
In the last couple of years the Gross Margin of SPCB has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 5.7%
GM 51.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y0.68%
SPCB Yearly Profit, Operating, Gross MarginsSPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
SPCB has less shares outstanding than it did 1 year ago.
SPCB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SPCB has been reduced compared to a year ago.
SPCB Yearly Shares OutstandingSPCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
SPCB Yearly Total Debt VS Total AssetsSPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.58, we must say that SPCB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SPCB (-1.58) is worse than 81.45% of its industry peers.
SPCB has a Debt/Equity ratio of 2.17. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.17, SPCB is doing worse than 94.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z -1.58
ROIC/WACCN/A
WACC6.2%
SPCB Yearly LT Debt VS Equity VS FCFSPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

SPCB has a Current Ratio of 5.10. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.10, SPCB belongs to the best of the industry, outperforming 83.06% of the companies in the same industry.
SPCB has a Quick Ratio of 4.66. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
SPCB has a better Quick ratio (4.66) than 85.48% of its industry peers.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 4.66
SPCB Yearly Current Assets VS Current LiabilitesSPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.38% over the past year.
The Revenue has been growing slightly by 4.25% in the past year.
SPCB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.34% yearly.
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)4.25%
Revenue growth 3Y-17.54%
Revenue growth 5Y-9.34%
Sales Q2Q%1.96%

3.2 Future

The Earnings Per Share is expected to grow by 14.96% on average over the next years. This is quite good.
Based on estimates for the next years, SPCB will show a very strong growth in Revenue. The Revenue will grow by 23.62% on average per year.
EPS Next Y77.78%
EPS Next 2Y42.83%
EPS Next 3Y26.8%
EPS Next 5Y14.96%
Revenue Next Year37.9%
Revenue Next 2Y45.91%
Revenue Next 3Y30.86%
Revenue Next 5Y23.62%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SPCB Yearly Revenue VS EstimatesSPCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
SPCB Yearly EPS VS EstimatesSPCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 100 150 200

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SPCB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 3.54, the valuation of SPCB can be described as very cheap.
98.39% of the companies in the same industry are more expensive than SPCB, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SPCB to the average of the S&P500 Index (21.38), we can say SPCB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.54
SPCB Price Earnings VS Forward Price EarningsSPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

62.10% of the companies in the same industry are more expensive than SPCB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.03
SPCB Per share dataSPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SPCB's earnings are expected to grow with 26.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3Y26.8%

More info and screens

0

5. Dividend

5.1 Amount

SPCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPERCOM LTD

NASDAQ:SPCB (4/25/2025, 8:00:02 PM)

After market: 7.99 +0.05 (+0.63%)

7.94

+0.23 (+2.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-23 2025-01-23/bmo
Earnings (Next)04-28 2025-04-28/amc
Inst Owners9.63%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.66M
Analysts82.86
Price Target14.28 (79.85%)
Short Float %8.11%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)226.05%
Min EPS beat(2)156.02%
Max EPS beat(2)296.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.57%
Min Revenue beat(2)17.85%
Max Revenue beat(2)23.28%
Revenue beat(4)4
Avg Revenue beat(4)21.66%
Min Revenue beat(4)1.03%
Max Revenue beat(4)44.46%
Revenue beat(8)8
Avg Revenue beat(8)38.35%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)142.5%
EPS NY rev (1m)-27.15%
EPS NY rev (3m)-27.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.54
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 27.1
EV/EBITDA 15.03
EPS(TTM)-2.82
EYN/A
EPS(NY)2.24
Fwd EY28.26%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS15.61
BVpS8.03
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.09%
ROE 11.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.7%
GM 51.8%
FCFM N/A
ROA(3y)-16.94%
ROA(5y)-19.82%
ROE(3y)-184.28%
ROE(5y)-170.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y0.68%
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA 12.23
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.1
Quick Ratio 4.66
Altman-Z -1.58
F-ScoreN/A
WACC6.2%
ROIC/WACCN/A
Cap/Depr(3y)89.28%
Cap/Depr(5y)71.34%
Cap/Sales(3y)12.83%
Cap/Sales(5y)11.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y77.78%
EPS Next 2Y42.83%
EPS Next 3Y26.8%
EPS Next 5Y14.96%
Revenue 1Y (TTM)4.25%
Revenue growth 3Y-17.54%
Revenue growth 5Y-9.34%
Sales Q2Q%1.96%
Revenue Next Year37.9%
Revenue Next 2Y45.91%
Revenue Next 3Y30.86%
Revenue Next 5Y23.62%
EBIT growth 1Y44.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.86%
EBIT Next 3Y73.76%
EBIT Next 5YN/A
FCF growth 1Y15.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.1%
OCF growth 3YN/A
OCF growth 5YN/A